Goldman Sachs Maintains Krystal Biotech (KRYS) Buy Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on May 22, 2023, Goldman Sachs maintained coverage of Krystal Biotech (NASDAQ:KRYS) with a Buy recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/stock-market-crash-sell-off---trading-screen-in-red-104271845-565bca2f055c47558a2d17ec3563a4dd.jpg "What Caused Black Monday, the 1987 Stock Market Crash?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1250102248-0880ddb69274491eb511def354c9ecbc.jpg "These Are the 5 Strongest Currencies in the World in October 2024")